A citation-based method for searching scientific literature

K Pabreja, M A Mohd, C Koole, D Wootten, S G B Furness. Br J Pharmacol 2014
Times Cited: 44







List of co-cited articles
422 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biology of incretins: GLP-1 and GIP.
Laurie L Baggio, Daniel J Drucker. Gastroenterology 2007
20

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
20

Allosteric ligands of the glucagon-like peptide 1 receptor (GLP-1R) differentially modulate endogenous and exogenous peptide responses in a pathway-selective manner: implications for drug screening.
Cassandra Koole, Denise Wootten, John Simms, Celine Valant, Rohan Sridhar, Owen L Woodman, Laurence J Miller, Roger J Summers, Arthur Christopoulos, Patrick M Sexton. Mol Pharmacol 2010
143
18

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways.
Kiwon Ban, M Hossein Noyan-Ashraf, Judith Hoefer, Steffen-Sebastian Bolz, Daniel J Drucker, Mansoor Husain. Circulation 2008
734
18

Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s).
Rasmus Jorgensen, Valentina Kubale, Milka Vrecl, Thue W Schwartz, Christian E Elling. J Pharmacol Exp Ther 2007
94
15

Investigating G protein signalling bias at the glucagon-like peptide-1 receptor in yeast.
C Weston, D Poyner, V Patel, S Dowell, G Ladds. Br J Pharmacol 2014
31
22

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
15

Structure of the human glucagon class B G-protein-coupled receptor.
Fai Yiu Siu, Min He, Chris de Graaf, Gye Won Han, Dehua Yang, Zhiyun Zhang, Caihong Zhou, Qingping Xu, Daniel Wacker, Jeremiah S Joseph,[...]. Nature 2013
271
13

Structure of class B GPCR corticotropin-releasing factor receptor 1.
Kaspar Hollenstein, James Kean, Andrea Bortolato, Robert K Y Cheng, Andrew S Doré, Ali Jazayeri, Robert M Cooke, Malcolm Weir, Fiona H Marshall. Nature 2013
305
13

Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function.
Cassandra Koole, Kavita Pabreja, Emilia E Savage, Denise Wootten, Sebastian G B Furness, Laurence J Miller, Arthur Christopoulos, Patrick M Sexton. Biochem Soc Trans 2013
49
13

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk, Hans Erik Bøtker, Won Yong Kim, Anders B Mathiasen, Erik Jørgensen, Steffen Helqvist, Kari Saunamäki, Peter Clemmensen,[...]. Eur Heart J 2012
380
13

Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells.
Noriyuki Sonoda, Takeshi Imamura, Takeshi Yoshizaki, Jennie L Babendure, Juu-Chin Lu, Jerrold M Olefsky. Proc Natl Acad Sci U S A 2008
136
11

GLP1-derived nonapeptide GLP1(28-36)amide protects pancreatic β-cells from glucolipotoxicity.
Zhengu Liu, Violeta Stanojevic, Luke J Brindamour, Joel F Habener. J Endocrinol 2012
63
11

Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets.
Loredana Farilla, Angela Bulotta, Boaz Hirshberg, Sergio Li Calzi, Nasif Khoury, Houtan Noushmehr, Cristina Bertolotto, Umberto Di Mario, David M Harlan, Riccardo Perfetti. Endocrinology 2003
474
11

Glucagon-like peptide-1 7-36: a physiological incretin in man.
B Kreymann, G Williams, M A Ghatei, S R Bloom. Lancet 1987
11


Small-molecule agonists for the glucagon-like peptide 1 receptor.
Lotte Bjerre Knudsen, Dan Kiel, Min Teng, Carsten Behrens, Dilip Bhumralkar, János T Kodra, Jens J Holst, Claus B Jeppesen, Michael D Johnson, Johannes Cornelis de Jong,[...]. Proc Natl Acad Sci U S A 2007
158
11

Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells.
C Montrose-Rafizadeh, P Avdonin, M J Garant, B D Rodgers, S Kole, H Yang, M A Levine, W Schwindinger, M Bernier. Endocrinology 1999
154
11


Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor.
Kiwon Ban, Kyoung-Han Kim, Chan-Kyung Cho, Meghan Sauvé, Eleftherios P Diamandis, Peter H Backx, Daniel J Drucker, Mansoor Husain. Endocrinology 2010
159
11


Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.
Amal K Bose, Mihaela M Mocanu, Richard D Carr, Christian L Brand, Derek M Yellon. Diabetes 2005
453
11

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
Thomas Nyström, Mark K Gutniak, Qimin Zhang, Fan Zhang, Jens Juul Holst, Bo Ahrén, Ake Sjöholm. Am J Physiol Endocrinol Metab 2004
492
11

GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.
Mohammad Hossein Noyan-Ashraf, M Abdul Momen, Kiwon Ban, Al-Muktafi Sadi, Yu-Qing Zhou, Ali M Riazi, Laurie L Baggio, R Mark Henkelman, Mansoor Husain, Daniel J Drucker. Diabetes 2009
398
11


Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
Lazaros A Nikolaidis, Dariush Elahi, Teresa Hentosz, Aaron Doverspike, Rhonda Huerbin, Lee Zourelias, Carol Stolarski, You-tang Shen, Richard P Shannon. Circulation 2004
389
11

Real-time trafficking and signaling of the glucagon-like peptide-1 receptor.
Sarah Noerklit Roed, Pernille Wismann, Christina Rye Underwood, Nikolaj Kulahin, Helle Iversen, Karen Arevad Cappelen, Lauge Schäffer, Janne Lehtonen, Jacob Hecksher-Soerensen, Anna Secher,[...]. Mol Cell Endocrinol 2014
92
11


Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations.
Denise Wootten, John Simms, Laurence J Miller, Arthur Christopoulos, Patrick M Sexton. Proc Natl Acad Sci U S A 2013
131
11

Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands.
Denise Wootten, Emilia E Savage, Francis S Willard, Ana B Bueno, Kyle W Sloop, Arthur Christopoulos, Patrick M Sexton. Mol Pharmacol 2013
56
11

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
9

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
9

Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study.
Sonal Singh, Hsien-Yen Chang, Thomas M Richards, Jonathan P Weiner, Jeanne M Clark, Jodi B Segal. JAMA Intern Med 2013
260
9


GLP-1(28-36) improves β-cell mass and glucose disposal in streptozotocin-induced diabetic mice and activates cAMP/PKA/β-catenin signaling in β-cells in vitro.
Weijuan Shao, Zhaoxia Wang, Wilfred Ip, Yu-Ting Chiang, Xiaoquan Xiong, Tuanyao Chai, Catherine Xu, Qinghua Wang, Tianru Jin. Am J Physiol Endocrinol Metab 2013
38
10


Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.
Kyle W Sloop, Francis S Willard, Martin B Brenner, James Ficorilli, Kathleen Valasek, Aaron D Showalter, Thomas B Farb, Julia X C Cao, Amy L Cox, M Dodson Michael,[...]. Diabetes 2010
107
9

Allosteric modulation of endogenous metabolites as an avenue for drug discovery.
Denise Wootten, Emilia E Savage, Celine Valant, Lauren T May, Kyle W Sloop, James Ficorilli, Aaron D Showalter, Francis S Willard, Arthur Christopoulos, Patrick M Sexton. Mol Pharmacol 2012
56
9

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
C Orskov, L Rabenhøj, A Wettergren, H Kofod, J J Holst. Diabetes 1994
714
9


Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure.
George G Sokos, Lazaros A Nikolaidis, Sunil Mankad, Dariush Elahi, Richard P Shannon. J Card Fail 2006
476
9

GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.
Charles Pyke, R Scott Heller, Rikke K Kirk, Cathrine Ørskov, Steffen Reedtz-Runge, Peter Kaastrup, Anders Hvelplund, Linda Bardram, Dan Calatayud, Lotte Bjerre Knudsen. Endocrinology 2014
401
9


Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line.
D J Drucker, J Philippe, S Mojsov, W L Chick, J F Habener. Proc Natl Acad Sci U S A 1987
628
9

GLP-1 and related peptides cause concentration-dependent relaxation of rat aorta through a pathway involving KATP and cAMP.
Brian D Green, Katharine V Hand, Janette E Dougan, Bronagh M McDonnell, Roslyn S Cassidy, David J Grieve. Arch Biochem Biophys 2008
114
9



GLP-1 and cardioprotection: from bench to bedside.
Susana Ravassa, Amaia Zudaire, Javier Díez. Cardiovasc Res 2012
71
9

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.
Yazhou Li, TracyAnn Perry, Mark S Kindy, Brandon K Harvey, David Tweedie, Harold W Holloway, Kathleen Powers, Hui Shen, Josephine M Egan, Kumar Sambamurti,[...]. Proc Natl Acad Sci U S A 2009
383
9

Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutation.
Cassandra Koole, Denise Wootten, John Simms, Celine Valant, Laurence J Miller, Arthur Christopoulos, Patrick M Sexton. Mol Pharmacol 2011
58
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.